Balyasny Asset Management
FMTX

Balyasny Asset Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Balyasny Asset Management’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,005,734
Closed -$20.1M – 3569
2022
Q3 		$20.1M Buy
1,005,734
+994,652
+8,975% +$13.1M 0.06% 429
2022
Q2 		$76K Buy
+11,082
New +$77.8K ﹤0.01% 2314
2021
Q2 		– Sell
-42,426
Closed -$1.19M – 2570
2021
Q1 		$1.19M Buy
+42,426
New +$1.53M 0.01% 1188

Balyasny Asset Management's FMTX Position: Q4 2022 in Review

Balyasny Asset Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 1,005,734 shares — an estimated $20.1M sold.

Balyasny Asset Management first reported a position in FMTX in Q1 2021 and held it in 3 quarters. The position peaked at $20.1M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Balyasny Asset Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 1,005,734 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $20.1M.
  • Balyasny Asset Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Balyasny Asset Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $20.1M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.